It takes time but most people adjust well to life after a diagnosis of lymphoma and find a 'new normal'. This might involve making some changes to your everyday life. In this section, you'll find information to help you live well with and beyond lymphoma.
The incidence mortality rate for all causes is 2 per every 100 patients per year. The OS of our cohort at 10 years from diagnosis was 76% (95% CI: 72–79) and 52% at 30 years (95% CI: 48–57).
Many people with Hodgkin lymphoma are cured, but the treatments used can lead to health problems in the future.
You may be relieved to finish treatment, but find it hard not to worry about the lymphoma coming back. (When cancer comes back after treatment, it is called recurrence.) This is a very common worry if you've had cancer. For some people, the lymphoma may never go away completely.
Current data from the National Cancer Institute (NCI) show an overall five-year relative survival rate of nearly 87 percent in patients with chronic lymphocytic leukemia (CLL), 88 percent in patients with Hodgkin lymphoma (HL), and 73 percent in patients with non-Hodgkin lymphoma (NHL).
Some types of lymphoma are more likely to relapse than others. In general, those that are more likely to relapse include: low-grade non-Hodgkin lymphomas and some types of high-grade non-Hodgkin lymphomas. Most types of classical Hodgkin lymphomas are less likely to relapse.
Lymphoma most often spreads to the liver, bone marrow, or lungs. Stage III-IV lymphomas are common, still very treatable, and often curable, depending on the NHL subtype. Stage III and stage IV are now considered a single category because they have the same treatment and prognosis.
Lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
This is a rare, slow-growing type of lymphoma. It's found mainly in the bone marrow, lymph nodes, and spleen. This type of lymphoma can't be cured. But people can live with it for many years.
Overall, the chance that a man will develop NHL in his lifetime is about 1 in 43; for a woman, the risk is about 1 in 53. But each person's risk can be affected by a number of risk factors. NHL can occur at any age. In fact, it is one of the more common cancers among children, teens, and young adults.
More than half of recurrences occur within two years of primary treatment. Up to 90% of recurrences happen before the five-year mark. The occurrence of relapse after 10 years is rare. After 15 years, developing lymphoma is the same as its risk in the normal population.
There is a chance that your treatment can increase the risk of getting another type of cancer in the future. This is because both chemotherapy drugs and radiotherapy work by damaging cells. They kill the lymphoma cells, but they can damage healthy cells too.
Overall, the average age of people when they are diagnosed is 39. Hodgkin lymphoma is rare in children younger than 5 years old. But it's the most common cancer diagnosed in adolescents ages 15 to 19 years. Incidence rates have declined by about 1% per year for Hodgkin lymphoma since the mid-2000s.
The 5-year survival rate for NHL in the United States is 74%. The survival rates for NHL vary based on several factors. These include the stage and subtype of cancer, a person's age and general health, and how well the treatment plan works.
Survival for all non-Hodgkin lymphomas
around 80 out of every 100 people (around 80%) survive their cancer for 1 year or more after they are diagnosed. around 65 out of every 100 people (around 65%) survive their cancer for 5 years or more after diagnosis.
Benign lymphoma, also called pseudolymphoma or benign lymphoid hyperplasia, is a rare noncancerous (benign) tumor made up of lymphocytes. Unlike other types of lymphoma, benign lymphoma is not cancer. Benign lymphoma may also be called follicular lymphoid hyperplasia or reactive lymphoid hyperplasia.
Predictive factors
In general, lymphoma is considered to be very treatable. However, each patient's outlook can vary based on several factors, most notably the type and severity of the diagnosis and how early the cancer was detected.
Stage 2. Around 90 out of 100 people (around 90%) will survive their Hodgkin lymphoma for 5 years or more after diagnosis.
Burkitt lymphoma grows very rapidly, which means that symptoms usually develop quickly, over just a few days or weeks. The most common symptom is one or more lumps, which often develop in several parts of your body. These are swollen lymph nodes.
If you have Hodgkin lymphoma that comes back, it may still be possible to get rid of your lymphoma again. This will mostly depend on: how well further treatment works for your type of Hodgkin lymphoma. the treatment you have already had.
There are very few cancers for which doctors will use the word “cure” right off the bat, but Hodgkin lymphoma (HL), the most common cancer diagnosis among children and young adults, comes pretty darn close: More than 90 percent of patients with stages 1 and 2 go on to survive five years or more, and even patients with ...
Some survivors of Hodgkin lymphoma have a higher risk of developing a secondary cancer, especially acute myeloid leukemia (after certain types of chemotherapy, like BEACOPP), non-Hodgkin lymphoma, lung cancer, or breast cancer.
Cancer survival rates often use a five-year survival rate. That doesn't mean cancer can't recur beyond five years. Certain cancers can recur many years after first being found and treated. For some cancers, if it has not recurred by five years after initial diagnosis, the chance of a later recurrence is very small.
In other words, the 5-year survival rate doesn't tell a person with cancer much about their future. The 5-year survival rate is a percentage indicating the proportion of people with a particular disease that will be alive after five years. No, it doesn't mean you have five years to live.
The disease usually starts in the upper body (neck, chest or armpits). Hodgkin lymphoma is one of the most curable forms of cancer. After treatment is complete, your care team will develop a survivorship plan that minimizes long-term side effects of treatment.